Artificial Intelligence (AI), particularly Generative AI, marks a substantial breakthrough in market research. In the ever-evolving landscape of applications and tools, staying current is half the battle. At Purdie Pascoe, we prioritize staying updated and adapting to market shifts while also being prudent in deploying AI, upholding data and privacy compliance.

Post-market clinical follow-up (PMCF) surveys have become a significant topic in the industry, offering a cost-effective solution for PMCF data collection. However, their effective implementation can be challenging. In this article, the PMCF experts at Purdie Pascoe focus on high-quality, case/patient-specific PMCF surveys that provide Level 4 data.

I still remember my first exposure to market research: it was in the late 90s, a few years before I moved into the industry myself, and I was working for a cellphone company. We were exploring the potential for mobile internet services, from shopping and gaming to stock trading and betting.

Watch this webcast with experts from Purdie Pascoe and Global RWC. Watch the webcast to gain key learnings such as proper survey planning , best practices for PMCF survey design  and what to do with your PMCF data.

Tumor agnostic indications present specific challenges that must be addressed to achieve a successful launch and ensure wide access for all patients. To prepare for these complex product and indications launches, it is paramount for commercial teams to gain insights on tumor agnostic testing behaviors, including awareness, adoption, drivers and barriers.

So, we now have our key brand metrics and understand which channels are preferred by our customers. But how do we turn this information into an action plan?

In brand equity research, stated importance is often used as the key measure of importance. Survey questions ask respondents to rank or rate attributes, providing researchers with direct, explicit data. While this approach provides a simple and cost-effective measure of importance, it suffers from inherent limitations.

In the healthcare industry, the COVID pandemic changed how we interact with our customers. We saw a rapid adoption of TeleHealth. Unable to access hospitals and clinics, sales reps had to find new ways of engaging with healthcare professionals, and healthcare companies increased their presence on social media platforms. We even had to learn how to make an impact at virtual conferences.

This article is the second part in a series where we examine the best way to drive brand growth and the market research approaches needed to support it.

This short article is the first part in a series where we examine the best way to drive brand growth and the market research approaches needed to support it.

Have you ever wondered what the best way is to drive the growth of your brand? At Purdie Pascoe, we have been looking into this, from a market research viewpoint, starting with a determination to be led by science rather than unfounded theories.

Many of the projects we do at Purdie Pascoe involve pricing or even have pricing as the principal objective. Our clients are constantly coming up with great new products, or improvements to existing ones, and they want to know if people will pay for them.

4th Medical Devices Regulatory and Compliance Online Summit (Vonlanthen Group)

Post market clinical follow-up (PMCF) surveys:

‘The ever-changing landscape’

Date: 24 - 25 March, 2022

Location: Virtual / Zoom

Doctors hate marketing. They’re always telling us that. They’re only interested in cold, hard evidence, not catchy slogans, or pictures of hopeful looking patients. Give us the facts, they say, don’t shower us in sentiment. Or (surely one of the most frustrating things for a marketeer to hear) “just make it less marketing-y”. But… we all know that underneath those white coats they’re just human beings like you and me.

One of the key aims for market researchers is to help our clients truly understand how their customers make decisions, and to identify and ideally quantify the most important choice drivers. Conjoint is one of our key tools for doing this.

Decentralized clinical trials have become the new normal during Covid times, and many advocate for this novel approach to grow into the industry standard. The days of solely focusing on key large centres for patient accrual are over, and this shift in paradigm can only benefit a greater number of cancer patients, everywhere.

Companion diagnostics (CDx) and laboratory diagnostic tests are key components of the patient pathway, especially in oncology. While the importance of biomarker testing and tumor profiling is more and more accepted by the medical community, few pharma and diagnostic companies have a solid handle on what drives testing behaviors.

As market researchers, we are frequently asked to identify the key drivers of a market, including prescribing or purchase behaviour. As human beings, we are often unaware of exactly what leads us to make certain decisions, so to focus on stated importance is flawed. Instead, we need to statistically derive the importance of key drivers, by assess correlations between different data points.

In your role, do you ever need to present geographical differences in data, either within a country or across countries? Excel spreadsheets or huge tables capture this information, but in a very dull, uninspiring way. A Heat Map could be the data visualisation tool that you are looking for.

Do you ever need to present large quantities of longitudinal data in a way that is digestible and engaging? Are you and your colleagues sick of static PowerPoint slides that represent one point in time but fail to effectively communicate insights over time? A bar chart race might be the answer.

New award-winning analysis of Coronavirus cases and deaths by English regions has found that areas with high risk of personal and material victimisation , income deprivation among under 60s and low skills and attainment suffered higher death rates from COVID-19. Significantly, areas with high proportions of non-whites and over 70s also had higher deaths per head of population when controlling for other relevant factors.

On Monday, 10th May, the BHBIA held their annual Best of Business Intelligence awards, aka The BOBI awards. We were delighted to win Analyst Team of the Year, in partnership with our friends at The Stats People, for our analysis of UK and International COVID-19 data.